Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Migraine Therapeutics Market to reach USD XX billion by the end of 2029

Global Migraine Therapeutics Market Size study & Forecast, by Therapeutics (Pain-relieving Medications, Preventive Medications), by Route of Administration (Oral & Nasal, Injectables), and Regional Analysis, 2022-2029

Product Code: HLSDT-49250458
Publish Date: 16-11-2022
Page: 200

Global Migraine Therapeutics Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. A crippling neurological condition called migraine is characterised by frequent occurrences of excruciatingly painful, throbbing headaches that can last up to three days. These headaches, which are typically unilateral, can last anywhere between four hours and three days. Pain is frequently accompanied by additional symptoms such perspiration, diarrhoea, tingling or numbness in the legs or extremities, nausea, vomiting, increased sensitivity to sound (phonophobia), increased sensitivity to light (photophobia), and vomiting.. To treat migraine, migraine therapeutics are being used. The Migraine Therapeutics market is expanding because of factors such as growing awareness about Migraine and its treatment options and increasing prevalence of Migraines along with high unmet needs. However, adverse effects of drugs and lack of proper diagnosis and increasing undiagnosed cases may halt market growth.

The American Food and Drug Administration (FDA) approved Lundbeck’s VYEPTI (eptinezumab-jjmr) in February 2020 for the adult population’s migraine prevention. Additionally, in May 2021, the United States Food and Drug Administration (FDA) approved Biohaven Pharmaceutical Holding Company Ltd.’s NURTEC ODT (rimegepant 75 mg) for the treatment of migraines before they start. Adult patients with episodic migraine, such as those who encounter fewer than 15 headache days per month, are advised to use NURTEC ODT. Over the projected term, these approvals drive the study market’s expansion. In addition, AbbVie reported favourable results from a phase 3 clinical trial testing atogepant (marketed as QULIPTA in the US) for the prevention of chronic migraine in adults in March 2022. It is an antagonist of the CGRP receptor that is taken orally (gepant). For both the 60 mg once daily (QD) and the 30 mg twice daily (BID) doses, the medication achieved the trial’s primary aim of a statistically significant reduction from baseline in mean monthly migraine days compared to placebo over the course of the 12-week treatment period. The successful launch of this Therapeutics may provide patients with an alternative option.

The key regions considered for the Global Migraine Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World.Due to the dominance of branded Therapeutics and the rising prevalence of diseases in the region, North America dominated the space in terms of revenue. In 2020, there will be approximately 37.3 million diabetics in the United States, including 28.7 million instances that have been diagnosed and 8.5 million cases that have not. Due to factors like growing geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active involvement of the government and nonprofit organisations in the market space, Asia Pacific is predicted to experience significant growth during the forecast period..

Major market players included in this report are:
Amgen
Abbvie Inc.
AstraZeneca
Eli Lilly and Co.
GlaxoSmithKline
Merck & Co., Inc.
Pfizer
Bausch Health
Teva Pharmac
Novartis AGeuticals

Recent Developments in the Market:
 In February 2022, the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) recently approved Rimegepant, a calcitonin gene-related peptide (CGRP) receptor antagonist, from Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. The oral dissolving tablet form of Rimegepant, which comes at a dose of 75 mg, is advised for use in the prevention of episodic migraine in adults who experience at least four migraine attacks per month as well as in the acute treatment of migraine with or without aura in adults.
 In Aug 2022, The U.S. Food and Drug Administration (FDA) approved an expanded label for Eli Lilly and Company’s rapid-acting Migraine Therapeutics, Lyumjev® (Migraine Therapeutics lispro-AABC injection) 100 units/mL indicated to improve glycemic control in adults with type 1 and type 2 diabetes, to include administration via continuous subcutaneous Migraine Therapeutics infusion (CSII) with a Migraine Therapeutics pump.
 In July 2021, BioDelivery Sciences announced the introduction of new drug, Elyxyb.It is one of the first adult ready-to-use oral solutions for the acute treatment of migraine, with or without aura, that the Food and Drug Administration has approved. .
Global Migraine Therapeutics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Therapeutics, Route of Administration, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Therapeutics offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Therapeutics:
Pain-relieving Medications
Preventive Medications

By Route of Administration:
Oral & Nasal
Injectables

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Migraine Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Migraine Therapeutics Market, by Therapeutics, 2019-2029 (USD Billion)
1.2.3. Migraine Therapeutics Market, by Route of Administration, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Migraine Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Migraine Therapeutics Market Dynamics
3.1. Migraine Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing Awareness about Migraine and its Treatment Options
3.1.1.2. Increasing Prevalence of Migraines along with High Unmet Needs
3.1.2. Market Challenges
3.1.2.1. Adverse Effects of Drugs
3.1.2.2. Lack of Proper Diagnosis and Increasing Undiagnosed Cases
3.1.3. Market Opportunities
3.1.3.1. Increasing R&D Expenditures Leading to High Pipeline Products
Chapter 4. Global Migraine Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Migraine Therapeutics Market, by Therapeutics
6.1. Market Snapshot
6.2. Global Migraine Therapeutics Market by Therapeutics, Performance – Potential Analysis
6.3. Global Migraine Therapeutics Market Estimates & Forecasts by Therapeutics, 2019-2029 (USD Billion)
6.4. Migraine Therapeutics Market, Sub Segment Analysis
6.4.1. Pain-relieving Medications
6.4.2. Preventive Medications
Chapter 7. Global Migraine Therapeutics Market, by Route of Administration
7.1. Market Snapshot
7.2. Global Migraine Therapeutics Market by Route of Administration, Performance – Potential Analysis
7.3. Global Migraine Therapeutics Market Estimates & Forecasts by Route of Administration, 2019-2029 (USD Billion)
7.4. Migraine Therapeutics Market, Sub Segment Analysis
7.4.1. Oral & Nasal
7.4.2. Injectables
Chapter 8. Global Migraine Therapeutics Market, Regional Analysis
8.1. Migraine Therapeutics Market, Regional Market Snapshot
8.2. North America Migraine Therapeutics Market
8.2.1. U.S. Migraine Therapeutics Market
8.2.1.1. Therapeutics breakdown estimates & forecasts, 2019-2029
8.2.1.2. Route of Administration breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Migraine Therapeutics Market
8.3. Europe Migraine Therapeutics Market Snapshot
8.3.1. U.K. Migraine Therapeutics Market
8.3.2. Germany Migraine Therapeutics Market
8.3.3. France Migraine Therapeutics Market
8.3.4. Spain Migraine Therapeutics Market
8.3.5. Italy Migraine Therapeutics Market
8.3.6. Rest of Europe Migraine Therapeutics Market
8.4. Asia-Pacific Migraine Therapeutics Market Snapshot
8.4.1. China Migraine Therapeutics Market
8.4.2. India Migraine Therapeutics Market
8.4.3. Japan Migraine Therapeutics Market
8.4.4. Australia Migraine Therapeutics Market
8.4.5. South Korea Migraine Therapeutics Market
8.4.6. Rest of Asia Pacific Migraine Therapeutics Market
8.5. Latin America Migraine Therapeutics Market Snapshot
8.5.1. Brazil Migraine Therapeutics Market
8.5.2. Mexico Migraine Therapeutics Market
8.6. Rest of The World Migraine Therapeutics Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Amgen
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Abbvie Inc.
9.2.3. AstraZeneca
9.2.4. Eli Lilly and Co.
9.2.5. GlaxoSmithKline
9.2.6. Merck & Co., Inc.
9.2.7. Pfizer
9.2.8. Bausch Health
9.2.9. Teva Pharmaceuticals
9.2.10. Novartis AG
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now